Moneycontrol PRO
HomeNewsGlenmarkpharma

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Bet on these two stocks for decent returns in short term, although market lacks momentum

    From the second week of October 21, momentum oscillator RSI (relative strength index - 14) is reading in a 'lower low lower high' formation on the weekly timeframe which indicates a lack of momentum in the current trend.

  • Hot Stocks | Here's why Aarti Industries, Glenmark Pharma, ICICI Prudential Gold ETF can give decent returns in short term

    RRG (Relative Rotation Graphs) analysis indicates expected outperformance from banks, metals and auto sectors and expected underperformance from realty, media and IT. Gold has registered fresh breakout on charts and likely to perform well.

  • Trade Spotlight | What should you do with Laurus Labs, Glenmark Pharma, Ashoka Buildcon, and Vakrangee?

    Here's what Karan Pai of GEPL Capital, recommends investors should do with these stocks when the market resumes trading today

  • Trade Spotlight | What should you do with Glenmark Pharma, Navin Fluorine, Raymond & Birlasoft stocks?

    Here's what Mazhar Mohammad of chartviewindia.in, recommends investors should do with these stocks when the market resumes trading today.

  • Hot Stocks | 'Can bet on VIP Industries, Rupa & Company, Glenmark Pharma for 10-15% gains in short term'

    Short-term trend is expected to remain positive for both Nifty and Bank Nifty. Next upside target for Nifty is seen around 18,200 and 18,450, said Nandish Shah of HDFC Securities.

  • Rally in broader markets not done yet, say experts; these 16 mid, smallcap stocks can give double-digit returns in 1 year

    Mid and smallcaps may cool off a little but this opportunity should be used to add quality stocks to your portfolio as the long-term market outlook is bullish, says experts

  • 3 stock ideas for next week: Nifty may march towards 15,000

    The daily strength indicator RSI and the momentum indicator Stochastic both have turned bullish along with positive crossover which is a positive bias.

  • Hot Stocks | Info Edge, Glenmark Pharma, Lupin can give up to 18% return in short term

    Call writers were seen adding hefty open interest at 14,500, 14,600 and 14,700 strikes which should act as a major hurdle for Nifty and will cap any sharp upside.

  • Here are 10 stocks for a 17-44% return for a one-year period

    This is the time to hunt for favourite fundamental stocks which are missing in your long-term portfolio. Experts say this is the time to take advantage of the price corrections

  • Union Budget 2021 likely to focus on infra, healthcare; analysts see these 10 stocks gaining

    D-Street is counting on key reforms in the Budget that could push growth and kicks tart the capex cycle in the economy.

  • Analysts recommend these 12 mid, smallcap stocks for healthy returns in 2021

    As of December 28 close, the BSE Sensex is up about 15 percent while the BSE Midcap index has gained 19 percent and the Smallcap index 31 percent in the calendar year 2020.

  • Experts stay positive on mid, smallcaps: These 20 stocks could give 14-64% returns

    Neeraj Chadawar of Axis Securities believes that market volatility is likely to provide good opportunities for Midcaps and Small caps.

  • Market to remain volatile till US elections, these 18 stocks can give 10-37% return

    Long-term investors should pick their favourite mid and smallcap shares gradually over the next few months, experts say.

  • Nifty likely to be in 11,385-11,625 range; 3 stock that can give 10-12% return

    In the daily time frame, the bullish momentum is losing steam as RSI has shifted to the sideways zone from the bullish zone.

  • Pharma: Is the show over or are there some fireworks left?

    After some tough years, the pharma sector is performing well and is around 25 percent up while the broader market is down 20 percent year-to-date.

  • Top buy and sell ideas by Ashwani Gujral, Mitesh Thakkar, Rajat Bose for short term

    Mitesh Thakkar of miteshthakkar.com recommends selling Bharat Forge with a stop loss of Rs 376 for target of Rs 350 and Britannia Industries with a stop loss of Rs 2840 for target of Rs 2720.

  • Brokerages initiate 'buy' on 9 stocks in March, see 24-56% upside in a year

    Correction is expected to continue, but this is the right time to accumulate quality stocks, most of experts feel

  • Top buy and sell ideas by Ashwani Gujral, Mitesh Thakkar, Prakash Gaba for short term

    Ashwani Gujral of ashwanigujral.com recommends buying Chambal Fertilizers with a stop loss of Rs 175, target of Rs 190 and Muthoot Finance with a stop loss of Rs 768, target of Rs 790.

  • Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

    Sudarshan Sukhani of s2analytics.com recommends buying Cadila Healthcare with stop loss at Rs 264 and target of Rs 279 and Colgate Palmolive with stop loss at Rs 1490 and target of Rs 1535.

  • Brokerages upgraded these 14 stocks, expect 10-60% returns in a year

    Maybank Kim Eng feels a more broad-based participation of stocks and sector rotation is a more likely trend in 2020.

  • Brokerages raise target price of these 10 large, midcap stocks post Q2 results

    The market traded in a range last week amid weak macro data, but inline performance of India Inc helped the Nifty close near its crucial support of 11,900.

  • Top 10 stocks that rose or fell in the week

    The S&P BSE Midcap index shed 1.31 percent, Smallcap Index was down 0.90 percent and S&P BSE Largecap Index fell 0.59 percent last week.

  • Chart Check: Where are Sun Pharma, Glenmark headed after a 5-10% fall in two days?

    Sun Pharma which reported healthy numbers in June quarter failed to hold onto gains and lost momentum largely due to growing concerns in US and management rejig

  • 'Bulls to gather strength, bet on these 3 stocks for double-digit returns'

    As long as the banking index is trading above 28,000, we suggest trading with buy on dip strategy. Moreover, the banking index can continue to trade in a range of 27,600-29,000 for the coming week.

  • Market Headstart: Nifty50 seen opening higher; 3 stocks which could give 5-10% return

    Trends on SGX Nifty indicate a higher opening for the broader index in India, a gain of 41 points or 0.35 percent. Nifty futures were trading around 11,643-level on the Singaporean Exchange.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347